Improved myocardial mitochondrial energy metabolism in rats with chronic heart failure by modifying fatty acid oxidation using an extract of sand-fired aconite (Jianchang gang processing)

Hongtao Zhang, Yi Zhang, Songhong Yang, Feipeng Gong, Yuncheng Gu, Qin Xie, Yanrong Ye, Xingmei Lu, Lingyun ZhongFrontiers in Pharmacology 2025 · DOI

This research paper, published in Frontiers in Pharmacology, investigates how a specific preparation of a traditional Chinese medicinal herb can physically and chemically "reboot" the failing heart's energy production system.

TL;DR

Researchers found that sand-fired aconite slices (SFAS) significantly improve cardiac function in rats with chronic heart failure (CHF). The treatment works by activating the AMPK/PGC-1α/SIRT3 signaling pathway, which restores the heart's ability to burn fatty acids for fuel and repairs damaged mitochondria.

What Problem Does This Paper Address?

The heart is an energy-hungry "engine" that primarily runs on fatty acid oxidation (FAO). In chronic heart failure, this engine breaks down: mitochondria (the cell's power plants) become structurally damaged, and the metabolic pathways for burning fat are disrupted, leading to an "energy crisis" in cardiac cells.

While Aconite (Aconitum carmichaelii Debx) has been used in Traditional Chinese Medicine (TCM) for centuries to treat heart conditions, it is notoriously toxic in its raw form. This study explores a specific processing technique called "Jianchang gang" (sand-firing) to see if it can effectively treat CHF by fixing mitochondrial metabolism without the associated toxicity, and specifically how it does so at a molecular level.

Methods

The researchers used a multi-disciplinary approach to evaluate SFAS:

  • Animal Model: Chronic heart failure was induced in Sprague-Dawley rats using doxorubicin (DOX), a chemotherapy drug known for its cardiotoxicity.
  • Chemical Profiling: Used UPLC-MS/MS to identify the specific alkaloid components in the sand-fired extract compared to other processing methods (like steaming or cooking).
  • Cardiac Imaging: High-resolution ultrasound (echocardiography) measured Left Ventricular Ejection Fraction (LVEF) and Shortening Fraction (LVFS).
  • Microscopy: Transmission Electron Microscopy (TEM) allowed for direct visualization of mitochondrial "cristae" (the internal folds where energy is produced).
  • Molecular Analysis: Western blotting and ELISAs quantified the expression of key metabolic proteins (CD36, CPT1) and the master regulatory pathway (AMPK, PGC-1α, SIRT3).

Datasets

The study did not use external public datasets but generated original experimental data from:

  • 132 male Sprague-Dawley rats divided into nine experimental groups (Control, CHF model, Captopril positive control, and various aconite preparations).
  • Chemical standards for 11 characteristic aconite alkaloids (e.g., Aconitine, Mesaconitine) used for quality control and profiling of the extracts.

Key Insights and Ideas

  • The Metabolic "Switch": In heart failure, the heart loses its ability to transport and burn fatty acids. SFAS upregulates CD36 (the "gatekeeper" that lets fat into the cell) and CPT1 (the enzyme that shuttles fat into the mitochondria), effectively flipping the metabolic switch back to a healthy state.
  • The AMPK/PGC-1α/SIRT3 Axis: This is the study's "aha moment." SFAS doesn't just provide fuel; it activates a regulatory cascade. AMPK acts as an energy sensor that triggers PGC-1α (the master regulator of mitochondrial biogenesis) and SIRT3 (which maintains mitochondrial health and reduces oxidative stress).
  • Processing is Critical: The "Jianchang gang" sand-firing method altered the alkaloid profile of the aconite, reducing toxic components while retaining high-efficiency cardiotonic compounds. The high-dose SFAS (SFAS-H) outperformed other traditional preparations like steamed or cooked aconite in several metabolic markers.

Key Results

  • Cardiac Rescue: SFAS-H restored LVEF from a failing 34.22% back to a near-normal 83.68% ($P < 0.001$).
  • Energy Boost: ATP production in the heart tissue nearly doubled, increasing from 2,869.85 nmol/mL in CHF rats to 5,483.17 nmol/mL after treatment.
  • Structural Repair: TEM imaging showed that while CHF mitochondria were swollen with fragmented internal structures, SFAS-treated mitochondria regained their regular shape and dense, parallel cristae.
  • Biomarker Reduction: Significant decreases were seen in clinical markers of heart stress, including BNP (reduced from 743.15 to 478.75 pg/mL) and ANP.

Limitations and Future Work

  • Metabolic Scope: The study focused almost exclusively on fatty acid oxidation. The authors acknowledge that glucose metabolism pathways (like PI3K/Akt/GLUT) were not evaluated, which also play a role in heart failure.
  • Gender Bias: Only male rats were used. TCM tradition suggests different aconite preparations might be more effective for different sexes (e.g., SFAS for males vs. DGSAS for females). Future studies need to include female models to validate these sex-specific claims.
  • Clinical Translation: While the rat data is compelling, the jump from a processed herbal extract in a controlled lab setting to a standardized human pharmaceutical remains a significant challenge.

Summary updated

Abstract

By activating the AMPK/PGC-1α/SIRT3 signaling pathway, SFAS ameliorated the impaired fatty acid oxidation pathway and enhanced mitochondrial function and antioxidant capacity in cardiomyocytes, ultimately reducing myocardial damage and restoring cardiac function in CHF rats.
BibTeX
@inproceedings{zhang2025improved,
  author = {Hongtao Zhang and Yi Zhang and Songhong Yang and Feipeng Gong and Yuncheng Gu and Qin Xie and Yanrong Ye and Xingmei Lu and Lingyun Zhong},
  title = {{Improved myocardial mitochondrial energy metabolism in rats with chronic heart failure by modifying fatty acid oxidation using an extract of sand-fired aconite (Jianchang gang processing)}},
  booktitle = {Frontiers in Pharmacology},
  year = {2025},
  doi = {10.3389/fphar.2025.1600410},
}
Figure